"Abbott Laboratories (NYSE: ABT) is continuing its long record of rewarding shareholders," notes Alex Kolb In Zacks Elite, pointing to its 341st consecutive quarter of dividends since 1924.

"Abbott is a global, broad-based health care company that develops, manufactures and markets pharmaceuticals and medical products, including nutritionals, devices and diagnostics.

"The company employs more than 68,000 people and markets its products in more than 130 countries.

"The company recently released new data, showing that a combination of its new TriLipix triglycerides medicine and a low dose of AstraZeneca's Crestor cholesterol drug are better than the individual pills for treating heart problems.

Continue reading Abbott (ABT): An 'income machine'

Abbott (ABT): An 'income machine' originally appeared on BloggingStocks on Tue, 14 Apr 2009 10:30:00 EST. Please see our terms for use of feeds.

"McDonald's (NYSE: MCD) has bucked the global recession in February as both global and U.S. same *store sales rose," says Tracey Ryniec, who has chosen the fast food giant as its latest featured company in Zacks Ellite Stock of the Day.

The analyst explains, "The company, which operates more than 32,000 McDonald's restaurants in over 100 countries, reported February comparable sales results on Mar 9 that showed global sales rising 1.4% year over year even as Feb 2008 included an extra day due to leap year. Excluding the extra day, sales grew 5.4%.

"U.S. sales climbed 2.8%, or 6.8% if you exclude the extra calendar day in 2008. Asia/Pacific, Middle East and Africa rose 0.7%, or 4.1% if you exclude the extra calendar day. Only Europe saw a decline, losing 0.2%, but if you exclude the extra day, even Europe increased 4%.

Continue reading Zacks Elite bites into Big Mac

Zacks Elite bites into Big Mac originally appeared on BloggingStocks on Thu, 19 Mar 2009 14:20:00 EST. Please see our terms for use of feeds.